Early research studies in Africa that found higher education was associated with a greater risk of HIV have often been dismissed as errors or anomalies, especially once later research suggested the opposite pattern. But a recently...
Giving adolescents living with HIV high-dose Vitamin D and calcium supplements can help improve their bone density and reduce the risk of fractures, a new study suggests.
Every day, millions of people around the world focus on living well with HIV, and that focus goes far beyond taking medication. While antiretroviral therapy (ART) is foundational to managing HIV, small daily choices around food, rest,...
A meta-analysis identifies immunosuppression and chronic kidney disease as carrying the highest risk for invasive pneumococcal disease in adults. Medscape News Europe
When healthcare systems overlook individuals at risk for HIV, community-led HIV support steps in to fill the gap. Across the globe, grassroots groups and peer-led networks are making a powerful difference in the lives of people often...
Living with HIV can be emotionally taxing, and many people face challenges such as anxiety, depression, and burnout. Understanding the importance of HIV mental health support is crucial for overall well-being and quality of life. Whether...
For many people living with HIV, finding acceptance and care within spiritual spaces can be life‑affirming. HIV support in faith communities has become a growing focus as congregations across the country move beyond judgment and toward...
Living as young adults with HIV comes with unique challenges, hopes, and opportunities. This article explores the voices and experiences of young people navigating school, relationships, mental health, and stigma. For many youth dealing...
Talking openly about HIV can be challenging, especially with partners, children, and other loved ones. Yet staying silent often fuels shame and misinformation rather than protection and understanding. Knowing how to talk to family about...
Living with HIV today is very different from what it was decades ago. Thanks to modern treatments, people with HIV are living longer and healthier lives. However, longer life also means a higher chance of facing other chronic health...
Understanding your HIV prevention options can feel overwhelming, especially with so many choices and medical terms involved. However, prevention tools like PrEP and PEP are more effective and more available than ever before. This article...
The global health community has set ambitious goals known as the HIV 95-95-95 targets, aiming for 95% of people living with HIV to know their HIV status, 95% of those diagnosed to be on antiretroviral therapy (ART), and 95% of those on...
Many people still see HIV testing as something to fear or avoid, rather than a routine and empowering part of health care. However, today’s testing is easier, faster, and more accessible than ever before. Normalizing HIV testing is not...
The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for gonorrhea, a common sexually transmitted... Reuters Health Information
Initiating antiretroviral therapy within 1 year of HIV infection is associated with a reduced risk for non-AIDS-defining malignancies compared with later initiation. Medscape Medical News
In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable pre-exposure prophylaxis (PrEP) in...
Sexual violence against children and intimate partner violence against women are two of the most devastating yet persistently underrecognized global health challenges and rank among the top risks for mortality and morbidity worldwide,...
An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of contracting the virus. Medscape News Canada
For the first time in more than three decades, the United States did not take part in World AIDS Day on December 1, a major change from past years when the day was used to raise awareness about HIV/AIDS and honor the millions of people...
Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes. Currently, nearly 40 million people...
Medical cannabis lacks adequate scientific backing for most of the conditions it is commonly used to treat, including chronic pain, anxiety and insomnia, according to a comprehensive review led by UCLA Health.
Kegoratile Aphane did not flinch when the needle pierced the skin of her right buttock, injecting a yellow-colored drug touted as a revolution that could end the HIV pandemic.
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, according to new research from the Valente lab at The Herbert Wertheim UF...
Details of a 60-year-old male individual from Germany who achieved sustained HIV remission after a stem cell transplant, the seventh-known case reported to date, are published in Nature this week.
For breastfeeding women who have HIV, consistently taking antiretroviral therapy (ART) is essential for their own health and the health of their infants. New long-acting (LA) injectable ART options, such as LA cabotegravir with...
As the world marks World AIDS Day on Dec. 1, world-renowned infectious disease expert Anthony Fauci, MD, and his colleague Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV that could finally end the...
A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, estimates that nearly 20% of U.S. residents who use pre-exposure prophylaxis (PrEP) for HIV prevention—or more...
Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies (bNAbs) can safely stop taking...
About 40 million people worldwide are living with HIV infection. In the United Kingdom, there are approximately 100,000 people affected. If the infection is not treated, the body will eventually be unable to defend itself against...
As the world marks World AIDS Day on Dec. 1, infectious disease expert Anthony Fauci, MD, and his colleague Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV that could finally end the pandemic, but...
A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment—an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.
HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life expectancy for people living with HIV. Nearly 41 million people were living with HIV in 2024. Eastern and...
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
An international team led by two Université de Montréal researchers has unveiled how a molecule capable of opening the "shell" of HIV improves the elimination of infected cells.
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) contains 31 recommendations and 10 good...
Europe is failing to test and treat HIV early, with over half (54%) of all diagnoses in 2024 being made too late for optimal treatment. New data released by the European Center for Disease Prevention and Control (ECDC) and the WHO...
The hepatitis C virus—HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens of millions of people worldwide and there is no vaccine to prevent infection, but effective...
Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a specific type of immune cell may contribute to the persistence of HIV infections. The finding offers new...
Leading community-led PrEP services are rethinking how they deliver services while reaching beyond their traditional user base. Facing waiting lists of thousands, the clinics are streamlining care and developing new strategies to engage...
While 41% of HIV-negative people from sexual and gender minorities in the UK are taking PrEP, figures drop to below 15% in most of the Balkans and eastern Europe, according to results from the European MSM Internet Survey (EMIS) 2024....
As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable form,...
An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of over 300 HIV strains tested, and blocked...
Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus can't reach the goal of viral imperceptibility even with daily doses of the potent medications.
Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute.
In an article published in The Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim to provide the most comprehensive estimates of pediatric mortality among children and adolescents...
The way gay and bisexual men are using drugs to enhance sex (chemsex) is changing in Europe, especially among younger men and those new to chemsex. They are turning to a new generation of drugs, generally with shorter half-lives. These...
A study presented at the recent 20th European AIDS Conference (EACS 2025) has found that the apparent rise in sexually transmitted infections (STIs), at least in gay and bisexual men with HIV in France, are due to more frequent testing...